The Microbiome in Cancer Development and Therapy

Microbiota can influence carcinogenesis via chronic inflammation, DNA damage, or altering immune responses. Certain bacteria like Fusobacterium nucleatum have been linked to colorectal cancer, while others enhance the efficacy of immunotherapy. This session explores the microbiome’s dual role in cancer—as a risk factor and therapeutic enhancer—and presents research on microbiome biomarkers, microbial drug metabolism, and potential interventions for cancer prevention and treatment optimization.

 

    The Microbiome in Cancer Development and Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in